NEWS
Coologics Announces Oversubscribed Seed Funding Round
April 23, 2025. Coologics announced the successful closing of their Seed round. The round was oversubscribed, demonstrating strong investor confidence in their flagship product, Vlisse.
Coologics’ Revolutionary Temperature-Based Approach To Vaginal Infections
Jan 9, 2024. Vlisse treats vaginal infections drug-free via temperature control, reducing inflammation & biofilms. Clinically proven for yeast/BV.